Schedule 13G ownership disclosure

ONCOMED PHARMACEUTICALS INC

Security class unavailable · CUSIP: 68234X102

Event date: 2016-08-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-16-005592
Form type
SC 13G
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
Aug 26, 2016
Reporting period
Aug 18, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub